Latest filing published 21 Oct 2022 for Aveo Pharmaceuticals, INC..
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Growth Equity Opportunities Fund IV, LLC: trading record in brief
This profile gathers the share dealings of Growth Equity Opportunities Fund IV, LLC in Aveo Pharmaceuticals, Inc. Between 8 April 2019 and 19 October 2022, the trades on record add up to 3 filings.
No open-market sale appears; the market trades are 2 purchases worth €11.1M. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant.
The record was last updated on 21 October 2022 with a transaction in Aveo Pharmaceuticals, Inc. The last insider purchase was made public on 22 June 2020, 2,331 days ago. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Growth Equity Opportunities Fund IV, LLC
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 3,952,957 shares0Common StockSEC:0001209191-22-054281:0
- 1,428,571 shares@ US$5.25100.0% of flowCommon StockSEC:0001209191-20-038234:0Canonical exit: 17 Sept 2020 (T+90)
- 4,347,827 shares@ US$1.1439.7% of flowCommon StockSEC:0001209191-19-023995:0Canonical exit: 7 Jul 2019 (T+90)
3 of 3 declarations
